1. Home
  2. IMMP vs BODI Comparison

IMMP vs BODI Comparison

Compare IMMP & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

N/A

Current Price

$3.60

Market Cap

31.5M

Sector

Health Care

ML Signal

N/A

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

N/A

Current Price

$4.57

Market Cap

34.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMP
BODI
Founded
1987
1998
Country
Australia
United States
Employees
N/A
270
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
34.3M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
IMMP
BODI
Price
$3.60
$4.57
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
★ 303.6K
19.1K
Earning Date
09-01-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 96.10
EPS
N/A
★ 0.47
Revenue
N/A
★ $251,727,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.09
P/E Ratio
★ N/A
$9.79
Revenue Growth
★ N/A
N/A
52 Week Low
$0.26
$4.05
52 Week High
$5.36
$16.87

Technical Indicators

Market Signals
Indicator
IMMP
BODI
Relative Strength Index (RSI) 67.55 35.00
Support Level $2.65 $4.54
Resistance Level $5.36 $5.11
Average True Range (ATR) 0.22 0.25
MACD 0.11 0.10
Stochastic Oscillator 64.73 35.63

Price Performance

Historical Comparison
IMMP
BODI

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

Share on Social Networks: